Following Occam’s razor in optometry

Article

I believe that the future of optometry, with all its hitches, challenges, and opportunities, is best met head-on if we all communicate effectively with one another.

The word “gratitude” doesn’t quite do it justice, but let me, nonetheless, begin by expressing my sincere gratitude to Dr. Ernie Bowling for his leadership and directive with Optometry Times.

I was fortunate to have dinner with him and Editor-in-Chief Gretchyn Bailey in Chicago a few weeks ago at the American Academy of Optometry’s annual meeting. It was a dinner table filled with, aside from some killer crab claws, lots of love and good vibes as we spoke of passing the Chief Optometric Editor baton.

Previously from Dr. Casella: The dangers of starting and stopping glaucoma treatment

Together with their staff, Ernie and Gretchyn have taken this relatively young publication to where it is today: among the most thoughtful and useful assemblages of advice for the doctor of optometry. Many of Ernie’s editorials have left me wondering just how in the heck he broke into my office and saw exactly the challenges with which I was dealing at that time.

This element of tangibility is part of the essence of Optometry Times that is so important to me, as a clinician, a small business owner, and a husband and father. I look forward to continuing to further that mission.

So, with that said, I’m Ben, and it’s nice to meet you. I own a single location practice in downtown Augusta, GA. Laura and I have two wonderful children (an 8-year-old boy and a 6-year-old girl). Our cat, Athena, however, is the CEO of the family.

Related: Optometry Times names new chief optometric editor

I work with my father in the practice his father founded in 1948. We stay pretty busy much of the time, and we deal with similar problems as everyone else. With my practice, as with most of life, I am a strong subscriber to Occam’s razor, the philosophical principle which tells us that the simplest explanation is usually correct. It is a theme in many of my lectures, and you may see elements of it in my editorials as I like to whittle things down into their simplest form in my quest for knowledge and answers.

This modus operandi doesn’t always lend itself readily to a profession as complex and multifactorial as that of optometry, but we press on. One of my goals is to make your monthly encounters with me via Optometry Times ones of a conversational nature. I’m no good at preaching my views, but I’m really good at having dialogue-I believe that the future of optometry, with all its hitches, challenges, and opportunities, is best met head-on if we all communicate effectively with one another.

Read more from Dr. Casella here

Recent Videos
Eye care practitioners reported moderate to high satisfaction with lifitegrast's ability to improve signs of dry eye, according to Melissa Barnett, OD, FAAO, FSLS.
Neda Gioia, OD, CNS, FOWNS, details the positive feedback gained so far from other optometrists that have been prescribing the NutriTears supplement to their dry eye patients.
Damaris Raymondi, OD, FAAO, highlighted the importance of building patient-doctor trust to learn about these practices, which can include non-traditional treatments like chamomile or manuka honey eye drops.
Noreen Shaikh, OD, Magdalena Stec, OD, FAAO, and Brenda Bohnsack, MD, PhD, emphasize that collaboration and communication are key to proper diagnosis and treatment.
Cecilia Koetting, OD, FAAO, DipABO, cited data from a recent student that found that presbyopia treatment with 0.4% pilocarpine led to up to 86% of patients achieving 20/40 or better.
Kerry Giedd, OD, MS, FAAO, was 1 of 20 investigators around the country for a study evaluating the daily disposable contact lens.
According to A. Paul Chous, MA, OD, FAAO, optometrists have an important opportunity to educate patients in their chairs about diabetes.
David Geffen, OD, FAAO, gave a poster presentation titled "Revolutionizing Comfort: Unveiling the Potential of Perfluorohexyloctane Eyedrops for Contact Lens Wearers" at this year's Academy meeting.
Jessica Steen, OD, FAAO, Dipl-ABO, discussed ophthalmic considerations for patients undergoing treatment with antibody drug conjugates for gynecologic cancers at this year's conference.
A. Paul Chous, MA, OD, FAAO, details a presentation on this year's updates on diabetes given at this year's Academy meeting
© 2024 MJH Life Sciences

All rights reserved.